| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | TS6G201A6Q |
| InChI Key | SCTZUZTYRMOMKT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H15F2NO |
| Molecular Weight | 323.34 |
| AlogP | 3.78 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 43.09 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 24.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Calcium-activated potassium channel
|
- | 6-11000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anemia, Sickle Cell | 3 | D000755 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL405821 |
| DrugBank | DB06280 |
| EPA CompTox | DTXSID60276906 |
| FDA SRS | TS6G201A6Q |
| Guide to Pharmacology | 2331 |
| SureChEMBL | SCHEMBL1443805 |
| ZINC | ZINC000003816408 |